Skip to content
Home/Companies/Pharma/Galenicum
GA

Galenicum

Pharma·Spain·Active·5yr hold

Galenicum is a healthcare company, headquartered in France.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Galenicum?

Galenicum is currently owned by Peninsula Capital through Peninsula Investments Europe (2017 vintage), since 2021. Across its history, Galenicum has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Peninsula Capital
Most recent investor
Peninsula Capital
Peninsula Investments Europe · 2017 · Private Equity
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods

Active
Co-held by Peninsula Capital and Peninsular Capital Management since 2021.
Peninsula Capital
Peninsula CapitalActive
2021 · present · Peninsula Investments Europe · 2017 · Private Equity
MOIC
–
PC
Peninsular Capital ManagementActive
present · Peninsular Capital Management Other Investments · Buyout
MOIC
–

More from Peninsula Investments Europe

Other portfolio companies in the same fund.

Neural Mentalia
Active
HealthcareSpain· 2025
Mattioli
Active
ConsumerItaly· 2024
Prima Industrie
Active
IndustrialsItaly· 2023
Veralab
Active
ConsumerItaly· 2023
ClubFunding
Active
FintechFrance· 2022
HLC Distribution
Active
ConsumerSpain· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Crossject
Active
VATEL CAPITALFrance· 2025
Data refreshed weekly · Sourced from public filings